4
MARKET OVERVIEW
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Maps the market evolution with focus on trend catalysts, risk factors, and growth opportunities across segments.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.4
TRENDS IN EUROPE HEALTHCARE ANALYTICS INDUSTRY
5.5.1
INDICATIVE PRICING OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT, 2022–2025
5.5.2
INDICATIVE PRICING OF HEALTHCARE ANALYTICS SOLUTIONS, BY COUNTRY, 2022–2025
5.6
KEY CONFERENCES AND EVENTS, 2025–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8
INVESTMENT AND FUNDING SCENARIO
5.10
IMPACT OF 2025 US TARIFF – EUROPE HEALTHCARE ANALYTICS MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRIES
5.11.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON EUROPE HEALTHCARE ANALYTICS MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
BEST PRACTICES IN EUROPE HEALTHCARE ANALYTICS
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN EUROPE HEALTHCARE ANALYTICS
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN EUROPE HEALTHCARE ANALYTICS
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
EUROPE HEALTHCARE ANALYTICS MARKET, BY COMPONENT (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
9.2.1.1
ANALYTICAL SERVICES
9.2.1.2
CONSULTING SERVICES
9.2.2
PROFESSIONAL SERVICES
9.2.2.1
TRAINING & IMPLEMENTATION SERVICES
9.2.2.2
MAINTENANCE & SUPPORT SERVICES
9.3.1
ON-PREMISE SOFTWARE
9.3.2
CLOUD-BASED SOFTWARE
10
EUROPE HEALTHCARE ANALYTICS MARKET, BY TYPE (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
10.2
DESCRIPTIVE ANALYTICS
10.3
PREDICTIVE ANALYTICS
10.4
PRESCRIPTIVE ANALYTICS
10.5
DIAGNOSTIC ANALYTICS
11
EUROPE HEALTHCARE ANALYTICS MARKET, BY APPLICATION (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
11.2.2
REVENUE CYCLE MANAGEMENT
11.2.3
PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
11.2.4
RISK ADJUSTMENT & ASSESSMENT
11.3.1
QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
11.3.2
CLINICAL DECISION SUPPORT
11.3.3
REPORTING & COMPLIANCE
11.3.4
COMPARATIVE ANALYTICS/EFFECTIVENESS
11.3.5
PRECISION HEALTH/REAL-WORLD EVIDENCE
11.3.6
MEDICAL IMAGING ANALYTICS
11.4
OPERATIONAL & ADMINISTRATIVE ANALYTICS
11.4.1
SUPPLY CHAIN ANALYTICS
11.4.2
WORKFORCE ANALYTICS
11.4.3
STRATEGIC ANALYTICS
11.5
POPULATION HEALTH ANALYTICS
12
EUROPE HEALTHCARE ANALYTICS MARKET, BY END USER (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
12.2.1
PRIVATE INSURANCE COMPANIES
12.2.2
GOVERNMENT AGENCIES
12.3.1
HOSPITALS & CLINICS
12.3.2
POST-ACUTE CARE ORGANIZATIONS
12.3.3
AMBULATORY SURGERY CENTERS
12.4
PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
12.4.2
DISTRIBUTORS & WHOLESALERS
13
EUROPE HEALTHCARE ANALYTICS MARKET, BY COUNTRY (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
14.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
14.4
MARKET SHARE ANALYSIS
14.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
14.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
14.6.5.1
COMPANY FOOTPRINT
14.6.5.2
COUNTRY FOOTPRINT
14.6.5.3
COMPONENT FOOTPRINT
14.6.5.4
APPLICATION FOOTPRINT
14.6.5.5
END-USER FOOTPRINT
14.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
14.7.1
PROGRESSIVE COMPANIES
14.7.2
RESPONSIVE COMPANIES
14.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
14.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
14.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
14.8
COMPANY VALUATION AND FINANCIAL METRICS
14.9
COMPETITIVE SCENARIO
15.1.2
SAS INSTITUTE INC.
15.1.6
EXLSERVICE HOLDINGS, INC.
15.1.10
MCKESSON CORPORATION
15.1.15
KONINKLIJKE PHILIPS N.V
15.1.16
SIEMENS HEALTHINEERS
15.2.4
TRANCEVERSE HEALTH
15.2.5
CEYLON GRAPHENE TECHNOLOGIES (PVT) LTD.
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
16.1.2.2
KEY PRIMARY PARTICIPANTS
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
16.1.2.4
KEY INDUSTRY INSIGHTS
16.2
MARKET SIZE ESTIMATION
16.2.1
BOTTOM-UP APPROACH
16.2.3
BASE NUMBER CALCULATION
16.3
MARKET FORECAST APPROACH
16.6
RESEARCH ASSUMPTIONS
16.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in Europe Healthcare Analytics Market